# Gem Premier 3000

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/gem-premier-3000-chl>
- Manufacturer: [Instrumentation Laboratory CO](https://devicerts.com/manufacturers/instrumentation-laboratory-company) (United States)
- Name in the registry: GEM PREMIER 3000
- Device class: Class II (US FDA)
- FDA product code: CHL

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K992834 · decision 1999-11-24 · decision SESE · status: Active

## Recalls

- Z-0357-2024 · Class II · ongoing · initiated 2023-09-29: Internal testing identified that the GEM Premier PAKs (cartridges) may exhibit an over-recovery (i.e., positive bias) of pO2 results in the low range (at pO2 levels less than 60 mmHg) that are outside of labeled performance specifications for pO2. The positive bias may lead to false positive for medical decision levels at pO2 \< 60 mmHg, which may result in failure to detect and/or adequately treat hypoxemia and lead to a delay in treatment. The quality control procedures for the Non-iQM GEM Premier 3000 may not detect the non-conformance.
- Z-0359-2024 · Class II · ongoing · initiated 2023-09-29: Internal testing identified that the GEM Premier PAKs (cartridges) may exhibit an over-recovery (i.e., positive bias) of pO2 results in the low range (at pO2 levels less than 60 mmHg) that are outside of labeled performance specifications for pO2. The positive bias may lead to false positive for medical decision levels at pO2 \< 60 mmHg, which may result in failure to detect and/or adequately treat hypoxemia and lead to a delay in treatment. The quality control procedures for the Non-iQM GEM Premier 3000 may not detect the non-conformance.
- Z-0358-2024 · Class II · ongoing · initiated 2023-09-29: Internal testing identified that the GEM Premier PAKs (cartridges) may exhibit an over-recovery (i.e., positive bias) of pO2 results in the low range (at pO2 levels less than 60 mmHg) that are outside of labeled performance specifications for pO2. The positive bias may lead to false positive for medical decision levels at pO2 \< 60 mmHg, which may result in failure to detect and/or adequately treat hypoxemia and lead to a delay in treatment. The quality control procedures for the Non-iQM GEM Premier 3000 may not detect the non-conformance.
- Z-0846-03 ·  · terminated · initiated 2003-03-07: Incorrect bar code applied to cartridges could result in inaccurate pO2 value
- Z-0845-03 ·  · terminated · initiated 2003-03-07: Incorrect bar code applied to cartridges could result in inaccurate pO2 value

## Identifiers

- 510(k) Number: K992834 [FDA 510(k)]
- FDA product code: CHL [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 862.1120 [FDA 510(k)]
- Advisory committee: Clinical Chemistry [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Gem Premier 3000, Instrumentation Laboratory CO. deviCERTS medical device catalogue. https://devicerts.com/devices/gem-premier-3000-chl (data as of 2026-11-18).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-10
- Statuses computed as of: 2026-11-18
- JSON: <https://devicerts.com/devices/gem-premier-3000-chl.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/gem-premier-3000-chl
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
